We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Silver Dressing Preserves Reparative Cells in Wounds

By HospiMedica International staff writers
Posted on 04 Sep 2009
An experimental approach to wound healing takes advantage of silver's antibacterial properties, sidestepping the damage it can cause to the cells needed for healing.

A researcher at the University of Wisconsin (Madison, USA) embedded silver nanoparticles within polyelectrolyte multilayers (PEMs), with 6.45 cm2 of the PEM material containing just 0.4% of the amount of silver that is usually found in the silver-treated antibacterial bandages currently used. More...
In laboratory tests, the low concentration of silver killed 99.9999% of the bacteria, but did not damage the fibroblast cells that are required to repair a wound. PEMs are constructed using a layer-by-layer deposition technique. During deposition, a suitable growth substrate (usually charged) is dipped back and forth between dilute baths of positively and negatively charged polyelectrolyte solutions. During each dip, a small amount of polyelectrolyte is adsorbed and the surface charge is reversed, allowing the gradual and controlled build-up of electrostatically cross-linked films of polycation-polyanion layers. A precise dose of silver is then added, since the system is so sensitive that increasing the silver dose from 0.4% to just 1% of the level commonly used in a commercial dressing severely damaged the fibroblasts. The study was presented at the American Chemical Society's national meeting and Exposition, held during August 2009 in Washington DC, (USA).

"This study goes beyond prior reports by characterizing the interactions of silver-impregnated polyelectrolyte multilayers with mammalian cells, and by identifying the minimum silver loading required for antibacterial activity,” said study presenter Ankit Agarwal, Ph.D. "A significant finding of the study is that it is indeed possible to design silver-loaded polyelectrolyte multilayers that exhibit antimicrobial activity while allowing attachment and spreading of mammalian cells.”

Silver is widely used as a biocidal agent in ointments and wound dressings. However, typical loadings of silver employed in silver delivery systems can cause tissue toxicity and impaired wound healing, and they have been shown to be cytotoxic to mammalian cells in vitro.

Related Links:

University of Wisconsin




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.